Education
About Us
Working with TipRanks
Follow Us
XBiotech Inc. (DE:4XB)
:4XB
4XB Stock Chart & Stats
€1.97
-€0.18(-4.33%)
At close: 4:00 PM EST
€1.97
-€0.18(-4.33%)
Day’s Range― - ―
52-Week Range€1.69 - €7.05
Previous CloseN/A
Volume0.00
Average Volume (3M)186.00
Market Cap
€61.73M
Enterprise ValueN/A
Total Cash (Recent Filing)€152.94M
Total Debt (Recent Filing)€0.00
Price to Earnings (P/E)―
Beta0.46
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.17
Shares Outstanding30,487,732
10 Day Avg. Volume560
30 Day Avg. Volume186
Financial Highlights & Ratios
PEG Ratio-0.06
Price to Book (P/B)0.66
Price to Sales (P/S)0.00
P/FCF Ratio-3.73
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
XBiotech News
4XB FAQ
What was XBiotech Inc.’s price range in the past 12 months?
XBiotech Inc. lowest stock price was €1.69 and its highest was €7.05 in the past 12 months.
What is XBiotech Inc.’s market cap?
XBiotech Inc.’s market cap is €61.73M.
When is XBiotech Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were XBiotech Inc.’s earnings last quarter?
Currently, no data Available
Is XBiotech Inc. overvalued?
According to Wall Street analysts XBiotech Inc.’s price is currently Overvalued.
Does XBiotech Inc. pay dividends?
XBiotech Inc. does not currently pay dividends.
What is XBiotech Inc.’s EPS estimate?
XBiotech Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does XBiotech Inc. have?
XBiotech Inc. has 30,487,732 shares outstanding.
What happened to XBiotech Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of XBiotech Inc.?
Currently, no hedge funds are holding shares in DE:4XB
XBiotech Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-68.20%
12-Months-Change
Fundamentals
Return on Equity
-15.23%
Trailing 12-Months
Asset Growth
-17.11%
Trailing 12-Months
Company Description
XBiotech Inc.
XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical conditions, such as cancer, stroke, heart attack, or arthritis; and mediates tissue breakdown, angiogenesis, the formation of blood clots, malaise, muscle wasting, and inflammation, and True Human COVID-19 therapy for treating the COVID-19 mutant virus. The company was incorporated in 2005 and is headquartered in Austin, Texas.
Technical Analysis
Alterity Therapeutics
―
Immunic
―
Nautilus Biotechnolgy
―
Acumen Pharmaceuticals
―
Invivyd
―
Options Prices
Currently, No data available
---